Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1 pathway comparison
Composition per vial: Follistatin (1mg)
Glucagon receptor activity and energy-expenditure pathway research
Product Size: 100mg vial
enhanced recovery
Retatrutide MOTS-c GLP-1 pathway comparisonRetatrutide Retatrutide is a triple receptor agonist studied for its relationship to GLP 1, GIP, and glucagon receptor signaling within metabolic research models. In research settings, Retatrutide is commonly evaluated in models involving incretin pathway activity, glucose response signaling, appetite regulation pathways, energy balance systems, and body composition associated metabolic adaptation. The Method 99% purity. Third party tested.
US$ 348.12
US$ 50.00
US$ 21.60
US$ 31.00
US$ 53.00
US$ 21300.00
US$ 1156.87
US$ 57.99
